Clinical Pharmacology‐Driven Translational Research to Optimize Bedside Therapeutics of Sotalol Therapy
Oral sotalol, used in adults for sinus rhythm control, is initiated at 80 mg b.i.d. and titrated to a maximum safe dose. The US Food and Drug Administration recommends monitoring the corrected QT interval (QTc) for at least 3 days, until steady‐state exposure of the drug is reached, before patient d...
Saved in:
Main Authors: | Elyes Dahmane (Author), Kathy Tang (Author), Jogarao V.S. Gobburu (Author), T. Joseph Mattingly II (Author), Brent N. Reed (Author), Vincent Y. See (Author), Joshuha Ayres (Author), Vijay Ivaturi (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dosage Regimens for Meropenem in Children with Pseudomonas Infections Do Not Meet Serum Concentration Targets
by: Hazem E. Hassan, et al.
Published: (2020) -
Spectrophotometric determination of sotalol in tablets
by: Y. M. Zhuk, et al.
Published: (2018) -
Assessment of Dofetilide or Sotalol Tolerability in the Elderly
by: Nikitha Yagnala PharmD, et al.
Published: (2024) -
Pharmacological β-adrenoceptor blockade can augment torsadogenic action of IKr inhibitor: Comparison of proarrhythmic effects of d-sotalol and dl-sotalol in the chronic atrioventricular block dogs
by: Ai Goto, et al.
Published: (2019) -
Bayesian model-guided antimicrobial therapy in pediatrics
by: Haden T. Bunn, et al.
Published: (2023)